TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract March 1, 1974